We are pleased to announce an MoU with JSS Medical College and Academy of Higher Education and Research, Mysuru to work together in the areas of hemoglobinopathies and rare diseases. The aim is to work on collaborative projects to develop affordable and efficient diagnostics, therapeutics, and treatment options.
Related Posts
Wastewater study detects a large, silent wave in Bengaluru
The XBB.1.16 Omicron recombinant first detected in India on December 25, 2022... read more
Our research is aimed at making treatment for rare genetic diseases affordable
In an exclusive interview to Gunjan Sharma from the HealthPost, Dr. Rakesh... read more
This discovery of 29 ‘new’ mosquito genes could open door to curbing malaria spread in India
A comprehensive genome sequencing of a Anopheles stephensi — a malaria-carrying mosquito found in... read more
COVID-19 in endemic stage, still need to monitor viral load, new variant: Top expert
Coronavirus is in the endemic stage but the viral load and emergence... read more
OneHealth national agenda meeting
A meeting at Indian Institute for Science (IISc), involving various academic, research... read more
Key insights of REDRESS 2023 featured in Biospectrum India
Rare Genetic Diseases Research Summit (REDRESS) 2023, an indigenous and recurrent platform... read more
Publication: Determinants of Aedes mosquito larval ecology in a heterogeneous urban environment – a longitudinal study in Bengaluru, India
In our latest longitudinal study from Bengaluru led by Farah Ishtiaq and... read more
PhD Admissions 2023
TIGS is proud to host a PhD program in collaboration with the... read more
Talk by Dr. Madhvi Joshi on ‘Learnings from Past: Extending Environmental Surveillance beyond COVID’
We were glad to host Dr. Madhvi Joshi, Scientist and Joint Director,... read more